Xamoterol

HCID 155774

Basic information

CAS
81801-12-9
Standard SMILES
O=C(NCCNCC(O)COc1ccc(O)cc1)N1CCOCC1
InChIKey
DXPOSRCHIDYWHW-UHFFFAOYSA-N
Molecular formula
C16H25N3O5
Average molar mass
339.39 g/mol
Monoisotopic mass
339.17942091

Names & identifiers

Preferred name
Xamoterol
IUPAC
N-[2-[[2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]morpholine-4-carboxamide
English name
XAMOTEROL HEMIFUMARATE
Molecular formula
C16H25N3O5.C4H4O4
Molecular weight
455.461

Names & synonyms

Xamoterol81801-12-9XamoterolumICI-118587DTXSID8045222N-[2-[[2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]morpholine-4-carboxamide7HE0JQL703N-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)morpholine-4-carboxamideICI-118,587N-(2-{[2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino}ethyl)morpholine-4-carboxamide4-Morpholinecarboxamide, N-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)-, (+-)-DTXCID6025222
Show more names
XAMOTEROL FUMARATEIxazomib Impurity 63XAMOTEROL HEMIFUMARATE USP/EP/BP4-Morpholinecarboxamide, N-[2-[[2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]-
(+-)-N-(2-((2-Hydroxy-3-(p-hydroxyphenoxy)propyl)amino)ethyl)-4-morpholinecarboxamideFumarate, XamoterolHemifumarate, XamoterolRefChem:195096Monohydrobromide, XamoterolMonohydrochloride, XamoterolC01CX07ICI118587

Database identifiers

CAS
81801-12-9
PubChem CID
155774
DTXSID
DTXSID8045222
ChEMBL
CHEMBL75753
ChEBI
CHEBI:10055
UNII
7HE0JQL703
Nikkaji
J3.731.223A、J304.911F

Properties

Computed structural properties

XLogP
-0.6
Topological polar surface area
103 Ų
Hydrogen bond donors
4
Hydrogen bond acceptors
6
Rotatable bonds
8
Heavy atoms
24

Physicochemical properties

Melting point
168 · 168-170°C
solubility
2 O: · H2O: 10 mg/mL at 60 °C, soluble
form
solid
color
white
FDA UNII
7 HE0JQL703 · 7HE0JQL703
Safety Statements
22 · 22-24/25

Safety & regulation

Safety data

wgk
3
safety_code
22-24/25

Chemistry & industry

Pharmacology

ATC Code · 2 items

C - Cardiovascular system;C01 - Cardiac therapy;C01C - Cardiac stimulants excl. cardiac glycosides;C01CX - Other cardiac stimulants;C01CX07 - Xamoterol

QC - Cardiovascular system;QC01 - Cardiac therapy;QC01C - Cardiac stimulants excl. cardiac glycosides;QC01CX - Other cardiac stimulants;QC01CX07 - Xamoterol

MeSH Pharmacological ClassificationCompounds that bind to and activate ADRENERGIC BETA-1 RECEPTORS.

Applications

UsesStimulant (cardiac).

UsesXamoterol is an authentic β1-adrenoceptor (β1-AR) agonist that has been shown to mimic the autoantibody effect on rat atria β1-AR apoptosis.

Suppliers12 total

LGM Pharma1-(800)-881-8210 · [email protected]
安耐吉化学&3A(安徽泽升科技有限公司)021-58432009 400-005-6266 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
陕西缔都医药化工有限公司+86-29-81139210 +86-17392587031 · [email protected]
上海陶术生物科技股份有限公司13564774135 · [email protected]

Additional notes

DefinitionChEBI: Xamoterol is a member of morpholines.

Related reactions

2 records

Compound notes

Loading…